On the other hand, RNF2 may promote the recruitment of immunosuppressive cells, such as MDSCs, and inhibit T cell activation (Liang et al., 2025), thereby regulating the immune escape capability of cervical cancer cells. Here, RNF2 is linked to cervical carcinoma.